H2B peptide directly binds to COMMD4 and inhibits its interactions, thereby increasing sensitivity to radiotherapy by causing DNA DSBs accumulation and mitotic catastrophe, suggesting COMMD proteins are potential targets for cancer therapy (Tang et al. 2023). This evidence concerns the gene COMMD4 and cancer.